EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.
Issue link: https://digital.eyeworld.org/i/978371
EW RESIDENTS 36 May 2018 EyeWorld journal club by Michael Ammar, MD, Michael Sulewski Jr., MD, Lindsay Dawson, MD, Rebecca Bausell, MD, Jaclyn Gurwin, MD, and Paul Tapino, MD, Scheie Eye Institute, University of Pennsylvania rent keratoplasty. Demographic information and preoperative data including best corrected visual acui- ty (BCVA), central corneal thickness (CCT), cataract grade, and severity of Fuchs' dystrophy (classified as mild, moderate, or advanced based on slit lamp biomicroscopy) were obtained. Postoperative outcome variables were BCVA, CCT, corneal edema, and clinically significant and 2017 included 207 eyes from 207 patients with FECD. Sixty-four patients underwent cataract sur- gery by FLACS and 143 underwent conventional phacoemulsification. Excluded were patients who had complications related to surgery, inadequate follow-up time, history of keratoplasty or glaucoma surgery, or patients with severe FECD, as these patients underwent concur- patients have accelerated endotheli- al cell loss and experience increased rates of corneal decompensation following phacoemulsification. Zhu et al. sought to determine if that translates clinically in this special patient population. This retrospective cohort study of cataract surgeries performed by multiple surgeons at Bascom Palmer Eye Institute between 2014 F emtosecond laser-assisted cataract surgery (FLACS) has been available for nearly a decade. One of the advan- tages of this technology is reduction in mechanical trauma, as lower and shorter durations of ultrasound energy are used in FLACS compared to traditional phacoemul- sification. 1 Several studies have shown a significant decrease in endothelial cell loss in patients who underwent FLACS, but no differ- ences in final visual or refractive outcomes. 2,3 It has been proposed that outcomes may be different in patients with Fuchs' endothelial corneal dystrophy (FECD), as these Review of "Outcomes of conventional laser-assisted cataract surgery in eyes Scheie Eye Institute, University of Pennsylvania residents, from left: Lindsay Dawson, MD, Rebecca Bausell, MD, Jaclyn Gurwin, MD, Michael Sulewski Jr., MD, and Michael Ammar, MD Paul Tapino, MD, residency program director, Scheie Eye Institute, University of Pennsylvania Does using the femtosecond laser confer greater endothelial safety over conventional phaco? The Uni- versity of Pennsylvania residents review a large retrospective study of Fuchs' patients appearing in the May issue of JCRS. —David F. Chang, MD, EyeWorld journal club editor